Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
Clinical trial NCT02831582 · COMPLETED
Trial details
- NCT number
- NCT02831582
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-12
- Primary completion
- 2021-12-11
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.